Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302.

Name: Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302.
Author: Martin, Lisa J

Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302. — المؤلف: Martin, Lisa J — Canadian Urological Association journal = Journal de l'Association des urologues

المؤلف: Martin, Lisa J
النشر: Canadian Urological Association journal = Journal de l'Association des urologues du Canada Jun 2019
الوصف: 192-200 p.